Stayble Therapeutics Financials
| STABL Stock | SEK 0.50 0.01 1.96% |
Stayble |
Please note, the imprecision that can be found in Stayble Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Stayble Therapeutics AB. Check Stayble Therapeutics' Beneish M Score to see the likelihood of Stayble Therapeutics' management manipulating its earnings.
Stayble Therapeutics Stock Summary
Stayble Therapeutics competes with Sprint Bioscience. Stayble Therapeutics AB develops injectable treatment for chronic low back pain triggered by disc degeneration. Stayble Therapeutics AB is based in Gothenburg, Sweden. Stayble Therapeutics is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0013513652 |
| Business Address | Arvid Hedvalls Backe |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.staybletherapeutics.se |
| Phone | 46 7 30 80 83 97 |
| Currency | SEK - Swedish Kronor |
You should never invest in Stayble Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Stayble Stock, because this is throwing your money away. Analyzing the key information contained in Stayble Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Stayble Therapeutics Key Financial Ratios
There are many critical financial ratios that Stayble Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Stayble Therapeutics reports annually and quarterly.| Return On Equity | -0.76 | |||
| Return On Asset | -0.44 | |||
| Beta | 0.76 | |||
| Z Score | 34.2 |
Stayble Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Stayble Therapeutics's current stock value. Our valuation model uses many indicators to compare Stayble Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stayble Therapeutics competition to find correlations between indicators driving Stayble Therapeutics's intrinsic value. More Info.Stayble Therapeutics AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Stayble Therapeutics' earnings, one of the primary drivers of an investment's value.Stayble Therapeutics Systematic Risk
Stayble Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Stayble Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Stayble Therapeutics correlated with the market. If Beta is less than 0 Stayble Therapeutics generally moves in the opposite direction as compared to the market. If Stayble Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Stayble Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Stayble Therapeutics is generally in the same direction as the market. If Beta > 1 Stayble Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Stayble Therapeutics April 4, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Stayble Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stayble Therapeutics AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stayble Therapeutics AB based on widely used predictive technical indicators. In general, we focus on analyzing Stayble Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stayble Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.26 | |||
| Information Ratio | 0.063 | |||
| Maximum Drawdown | 31.66 | |||
| Value At Risk | (10.20) | |||
| Potential Upside | 17.39 |
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.